Don B. Sanders - Concepedia

Author

Don B. Sanders

Also Known As

D B Sanders, D Bradford Sanders, D. B. SANDERS, D. B. Sanders, D. Bradford Sanders, D. Sanders, D.B Sanders, D.B. Sanders, DB Sanders, Db Sanders

183

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

University of Washington Indiana University – Purdue University Indianapolis University of Wisconsin–Madison Riley Hospital for Children Indiana University School of Medicine

About

Don B. Sanders is an author at University of Washington specializing in medicine, pulmonary medicine, and pulmonary fibrosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	990
2	Health Sciences	2	2	66
3	Public Health	1	1	26
4	Cell Biology	1	1	15
5	Cellular Physiology	1	1	15

Don B. Sanders

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation Don B. Sanders, Rachel Bittner, Margaret Rosenfeld, American Journal of Respiratory and Critical Care Medicine	2010	514
Pulmonary exacerbations are associated with subsequent FEV<sub>1</sub> decline in both adults and children with cystic fibrosis Don B. Sanders, Rachel Bittner, Margaret Rosenfeld, Pediatric Pulmonology	2010	250
Mycophenolate mofetil for myasthenia gravis: An open-label pilot study Emma Ciafaloni, Janice M. Massey, B. Tucker–Lipscomb, Neurology Mycophenolate MofetilClinical TranslationBiomedical ResearchPharmacologyClinical Trials	2001	184
Mycophenolate mofetil for myasthenia gravis Matthew N. Meriggioli, Emma Ciafaloni, Kefah Al‐Hayk, Neurology Medicinal ChemistryMycophenolate MofetilPharmaceutical ScienceAutoimmune DiseaseMedicine	2003	145
Return of FEV<sub>1</sub> after pulmonary exacerbation in children with cystic fibrosis Don B. Sanders, Lucas R. Hoffman, Julia Emerson, Pediatric Pulmonology	2010	135
Risk factors for lung function decline in a large cohort of young cystic fibrosis patients Jonathan D. Cogen, Julia Emerson, Don B. Sanders, Pediatric Pulmonology	2015	123
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell, The Lancet Respiratory Medicine MedicineHypertonic SalineDornase AlfaPulmonary Fibrosis	2022	116
Diagnosis of Cystic Fibrosis in Screened Populations Philip M. Farrell, Terry B. White, Michelle S. Howenstine, The Journal of Pediatrics Diagnostic CriterionDiagnosisScreeningDisease DiagnosisCytopathology	2017	112
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations Natalie E. West, Valeria Beckett, Raksha Jain, Journal of Cystic Fibrosis	2017	96
Outcomes of Infants With Indeterminate Diagnosis Detected by Cystic Fibrosis Newborn Screening Clement L. Ren, A. K. Fink, Kristofer Petren, PEDIATRICS	2015	90

Page 1